Purpose of reviewRisk stratification for chronic kidney is becoming increasingly important as a clinical tool for both treatment and prevention measures. The goal of this review is to identify how machine learning tools contribute and facilitate risk stratification in the clinical setting.Recent findingsThe two key machine learning paradigms to predictively stratify kidney disease risk are genomics-based and electronic health record based approaches. These methods can provide both quantitative information such as relative risk and qualitative information such as characterizing risk by subphenotype.SummaryThe four key methods to stratify chronic kidney disease risk are genomics, multiomics, supervised and unsupervised machine learning methods. Polygenic risk scores utilize whole genome sequencing data to generate an individual's relative risk compared with the population. Multiomic methods integrate information from multiple biomarkers to generate trajectories and prognostic different outcomes. Supervised machine learning methods can directly utilize the growing compendia of electronic health records such as laboratory results and notes to generate direct risk predictions, while unsupervised machine learning methods can cluster individuals with chronic kidney disease into subphenotypes with differing approaches to care.

Original languageEnglish
Pages (from-to)548-552
Number of pages5
JournalCurrent Opinion in Nephrology and Hypertension
Issue number6
StatePublished - 1 Nov 2022


  • chronic kidney disease
  • genomics
  • machine learning
  • multiomics
  • subphenotype


Dive into the research topics of 'Machine learning for risk stratification in kidney disease'. Together they form a unique fingerprint.

Cite this